Cargando…
Reply to Yalta and Yetkin—Cardiac Sarcoidosis: Indications for Implantable Cardioverter-Defibrillator Therapy
Autores principales: | Duffett, Stephen A., Paulin, Frédéric L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486858/ https://www.ncbi.nlm.nih.gov/pubmed/36148259 http://dx.doi.org/10.1016/j.cjco.2022.08.001 |
Ejemplares similares
-
Cardiac Sarcoidosis: Indications for Implantable Cardioverter-Defibrillator Therapy
por: Yalta, Kenan, et al.
Publicado: (2022) -
Reply to the Editor— Strategy for revision of subcutaneous implantable cardioverter-defibrillator following inappropriate shock
por: Do, Khuyen, et al.
Publicado: (2019) -
Evolving use and indications for implantable cardioverter defibrillators
por: de Groot, J. R.
Publicado: (2018) -
Induced atrial fibrillation during defibrillation test on implantation of subcutaneous implantable cardioverter defibrillator
por: Kim, Ki-Hun, et al.
Publicado: (2020) -
Subcutaneous implantable cardioverter-defibrillator (S-ICD) for secondary prevention of sudden cardiac death
por: Kempa, Maciej, et al.
Publicado: (2016)